Financial Gravity Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Financial Gravity Asset Management’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6	Closed	-$296	–	268
2020 Q1	$296	Sell	6 -15	-71%	-$799	﹤0.01%	647
2019 Q4	$62K	Sell	21 -3	-13%	-$186	0.04%	527
2019 Q3	$1K	Sell	24 -6	-20%	-$446	﹤0.01%	1016
2019 Q2	$3K	Sell	30 -483	-94%	-$43.4K	﹤0.01%	792
2019 Q1	$49K	Buy	+513	New	+$46K	0.04%	320
2018 Q3	$4K	Buy	61 +13	+27%	+$1.3K	﹤0.01%	763
2018 Q2	$5K	Sell	48 -84	-64%	-$8.38K	﹤0.01%	741
2018 Q1	$13K	Buy	+132	New	+$10.2K	0.01%	548

Other funds holding ENTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Financial Gravity Asset Management's ENTA Position: Q2 2020 in Review

Financial Gravity Asset Management sold out of Enanta Pharmaceuticals (ENTA) in Q2 2020, closing a stake of 6 shares — an estimated $296 sold.

Financial Gravity Asset Management first reported a position in ENTA in Q1 2018 and held it in 8 quarters. The position peaked at $62K in Q4 2019. 180 funds tracked by Wall St. Rank hold ENTA as of Q2 2020.

Financial Gravity Asset Management reported no remaining Enanta Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Financial Gravity Asset Management sold 6 Enanta Pharmaceuticals shares in Q2 2020, an estimated $296.
Financial Gravity Asset Management first reported a position in Enanta Pharmaceuticals in Q1 2018 and held it in 8 quarters.
Financial Gravity Asset Management's Enanta Pharmaceuticals position peaked at $62K in Q4 2019.
180 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2020.

Based on Financial Gravity Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.